Alembic Pharma announces US FDA tentative approval for Ivosidenib tablets 250 mg EP News Bureau Jul 5, 2024 The approved ANDA is therapeutically equivalent to the RLD product, Tibsovo Tablets, 250 mg, of Servier Pharmaceuticals
